Abstract. While a number of microbial infections induce a transient burst in viral load in individuals infected with human immunodeficiency virus-1 (HIV-1), a recent study has suggested that scrub typhus may suppress HIV-1 infection. We investigated the effects of Orientia tsutsugamushi on HIV-1 infection. In vitro HIV-1 infection experiments were conducted using peripheral blood mononuclear cells (PBMC) acutely infected with R5 and X4 HIV-1 or PBMC derived from patients receiving highly active antiretroviral therapy (HAART) whose plasma viral load was undetectable. Stimulation of PBMC with O. tsutsugamushi induced production of proinflammatory cytokines and ␤-chemokines, and markedly down-regulated expression of CCR5. Although pretreatment with O. tsutsugamushi rendered PBMC resistant to R5 HIV-1, it otherwise enhanced HIV-1 replication. Stimulation by O. tsutsugamushi induced HIV-1 replication in PBMC from patients receiving HAART. These findings suggest that scrub typhus does not necessarily suppress HIV-1 infection and does have potential to enhance HIV-1 replication.
INTRODUCTION
Immune activation or perturbation of cytokine networks following microbial coinfections generally increases human immunodeficiency virus-1 (HIV-1) viremia. However, Watt and others have recently reported the possible HIV-1-inhibitory effects of scrub typhus, 1 which is an acute febrile disease that is endemic in tropical Asia where HIV-1 infection is also prevalent. Their hypothesis is intriguing but also remains somehow speculative, partly because of difficulty in conducting a prospective and well-controlled clinical study in Thailand, as well as a lack of precise laboratory data supporting their hypothesis. We investigated effects of Orientia tsutsugamushi infection on in vitro HIV-1 infection of peripheral blood mononuclear cells (PBMC).
MATERIALS AND METHODS

Cells.
The PBMC were isolated from healthy volunteers who were not infected with HIV, as described previously. 2 
Resting CD4
+ T cells were isolated from HIV-1-infected individuals whose plasma viral RNA was undetectable upon receiving highly active antiretroviral therapy (HAART), as described previously. 3, 4 Viruses and rickettsiae. Virus stocks were prepared by transfecting 293 cells with the following HIV-1 infectious molecular clones:
2 AD8 (subtype B, R5), YU-2 (subtype B, R5), NL4-3 (subtype B, X4), ELI1 (subtype B, X4), 89.6 (subtype B, R5X4), and 93JP-NH1 (subtype E, R5X4). The proinflammatory cytokines tumor necrosis factor-␣ (TNF-␣) and interleukin-1␤ (IL-1␤), as well as the ␤-chemokines regulated upon activation normal T cell expressed and secreted (RANTES) protein and macrophage inflammatory protein-1␤, were not detected in these virus stocks.
Cell-free stocks of O. tsutsugamushi strains Karp or Kuroki were propagated in L929 cells. 5 In certain experiments, O. tsutsugamushi stocks were pretreated at 56°C for 60 minutes. Rickettsial replication was not detected by the L929 cell culture method.
Infections. For acute infection experiments, PBMC derived from healthy volunteers were mock-infected or infected with cell-free stocks of O. tsutsugamushi strains Karp or Kuroki, and then infected with HIV-1 stocks. Inocula were standardized by reverse transcriptase (RT) activity (10,000 cpm per 4 × 10 5 cells, as determined by RT assays). Viral replication was monitored by RT activity in cell-free culture supernatants. 2 For reactivation experiments, PBMC derived from patients receiving HAART were mock-infected or infected with the Karp strain, and viral replication was monitored by measuring p24 antigen levels in cell-free culture supernatants. 3, 4 Single-round viral replication assays. A replicationincompetent luciferase-reporter recombinant virus NL4-3luc-R − E − was pseudotyped with envelope (env) protein from R5 HIV-1 JRFL or X4 HIV-1 HXB2. 2 The PBMC were not treated, pretreated, or post-treated with the Karp strain (live or heat-inactivated) or supernatants from O. tsutsugamushi (Karp strain)-infected autologous PBMC, and luciferase activity in the infected cell lysates was determined. tsutsugamushi can induce HIV-1 replication from PBMC derived from HIV-1-infected individuals whose plasma viral RNA was undetectable after HAART. Apheresis to obtain PBMC was performed according to protocol approved by the National Institute of Allergy and Infectious Diseases Institutional Review Board (Bethesda, MD). The CD8 + T cells and HLA-DR + cells were depleted by Dynabeads (Dynal, Lake Success, NY) CD8 and HLA-DR, and there were less than 0.1% HLA-DR + CD4 + T cells (activated CD4 + T cells) in the remaining PBMC preparations. These cells did not release HIV-1 p24 antigen without any stimulation; however, stimulation with phytohemagglutinin plus IL-2 induced in vitro HIV-1 replication in all patients tested (Table 2) . When these cells were stimulated with O. tsutsugamushi, HIV-1 replication was induced in two of the four patients tested (Table 2) . Thus, O. tsutsugamushi stimulation appears to have capability of inducing HIV-1 replication in patients whose plasma viremia is undetectable.
DISCUSSION
Orientia tsutsugamushi is a gram-negative bacillus that is an obligate intracellular parasite, and is distributed in many Asian countries and Pacific islands. Since HIV-1 infection is HIV-1 AND SCRUB TYPHUS INFECTION also endemic in some of these areas, interaction between the two microorganisms may have clinical significance. In this regard, a recent study from Thailand has reported that acute scrub typhus infection may suppress HIV-1 infection, 1 which is in striking contrast to many other microbial coinfections that generally result in enhanced replication of HIV-1. 9 However, difficulty in conducting a prospective and wellcontrolled clinical study in Thailand, as well as the lack of precise laboratory data supporting their hypothesis, has resulted in substantial controversy.
Our in vitro study has suggested that O. tsutsugamushi infection had impacts on HIV-1 infection in several different ways, and that the net effect depends upon the balance of positive and negative factors. Difference in the net effects observed among different donors is intriguing and deserves further evaluation. Our preliminary data suggest that a number of host factors are involved in such variability (Moriuchi M, Moriuchi H, unpublished data). For example, while upregulation of HIV-1 expression from the LTR promoter secondary to proinflammatory cytokine production would benefit HIV-1 infection, down-regulation of CCR5 expression as well as production of chemokines would inhibit HIV-1 entry. Activation of LTR by microbial stimulation has been demonstrated in a variety of other co-infections. 9 We have previously reported similar dichotomous effects of bacterial cell wall components such as lipopolysaccharide (LPS) of gramnegative bacilli, lipoteichoic acid of gram-positive cocci, and lipoarabinomannan of mycobacteria on HIV-1 infection. 2 Our results in the present study were not unexpected, since O. tsutsugamushi contains LPS in its cell wall structure, although rickettsial LPS generally has weaker endotoxin activity than that of other gram-negative bacilli. Thus, although it is still possible that in vivo infection with O. tsutsugamushi may have substantially distinct effects on HIV-1 infection, our in vitro study suggests that scrub typhus does not necessarily suppress HIV-1 infection and does have potential to enhance HIV-1 replication.
Interactions between HIV and other microbes do not appear to be simple. Recently, measles infection has been shown to suppress HIV viremia in patients, 10 and we have also demonstrated that malaria parasites may suppress HIV-1 infec- tion in vitro. 11 Further studies are required for better understanding of interaction between these microbes and HIV-1 in co-infected patients. 
